Integrative Proteomics: Druggability rules

A target is conventionally considered to be validated when there is evidence that modulation of a target molecule will produce a desired biological effect. Integrative Proteomics Inc. is taking that definition one step further. It hopes to churn out higher quality targets by defining a validated target as one that not only plays a role in a biological pathway, but also is one that is

Read the full 651 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE